MedPath

GENVOYA 150mg/150mg/200mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULA

GENVOYA 150mg/150mg/200mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULA

Pending
Register Number

1151061001IP

Prescription Type

Uso Hospitalario

Authorization Date

Jun 21, 2021

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1151061001IP
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (4)

COBICISTATActive
Quantity: 150 mg
Name: COBICISTAT
ELVITEGRAVIRActive
Quantity: 150 mg
Name: ELVITEGRAVIR
EMTRICITABINAActive
Quantity: 200 mg
Name: EMTRICITABINA
TENOFOVIR ALAFENAMIDAActive
Quantity: 10 mg
Name: TENOFOVIR ALAFENAMIDA

ATC CLASSIFICATION (3)

J05A
J05AR
J05AR18

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.